| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| halothane | Inhalation | N/A | |
| isoflurane | Inhalation | N/A | |
| nitrous oxide | Inhalation | N/A | |
| oxygen | Inhalation (medicine gas) | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ketamine | Injection | 50 mg (as hydrochloride)/mL in 10-mL vial | |
| thiopental | Powder for injection | 1 g |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| bupivacaine | Injection | 0.25% (hydrochloride) in vial | |
| bupivacaine | Injection | 0.5% (hydrochloride) in vial | |
| lidocaine | Injection | 2% (hydrochloride) in vial | |
| lidocaine | Injection | 5% (chlorhydrate) | |
| lidocaine + epinephrine (adrenaline) | Solution for injection | 2% 1:80.000 |
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| epinephrine (adrenaline) | Injection | 30 mg/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| oxygen | Inhalation (medicine gas) | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetylsalicylic acid | Tablet | 100 mg to 500 mg | |
| diclofenac | Injection | 75mg/mL | |
| ibuprofen | Oral liquid | 200 mg/5 mL | a |
| ibuprofen | Tablet | 200 mg | |
| ibuprofen | Tablet | 400 mg | |
| ibuprofen | Tablet | 600 mg | |
| naproxen | Tablet | 250 mg | |
| naproxen | Tablet | 500 mg | |
| naproxen | Tablet | 550 mg | |
| paracetamol | Suppository | 100 mg | |
| paracetamol | Tablet | 100 mg to 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| codeine | Tablet | 30 mg (phosphate) | |
| morphine | Injection | 10 mg/ml | |
| morphine | Oral liquid | 10 mg/5 ml | |
| morphine | Tablet (controlled release) | 10 mg | |
| morphine | Tablet (prolonged release) | 20 mg- 200 mg |
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amitriptyline | Tablet | 10 mg | |
| amitriptyline | Tablet | 25 mg | |
| amitriptyline | Tablet | 75 mg | |
| cyclizine | Injection | 50 mg/ml | |
| cyclizine | Tablet | 50 mg | |
| dexamethasone | Injection | 4 mg/mL | |
| dexamethasone | Oral liquid | 2 mg/5 mL | |
| dexamethasone | Tablet | 2 mg | |
| dexamethasone | Tablet | 4 mg | |
| diazepam | Injection | 2 mg/5 mL | |
| diazepam | Injection | 5 mg/mL | |
| diazepam | Rectal solution | 10 mg | |
| diazepam | Rectal solution | 2.5 mg | |
| diazepam | Rectal solution | 5 mg | |
| diazepam | Tablet | 10 mg | |
| diazepam | Tablet | 2 mg | |
| diazepam | Tablet | 5 mg | |
| docusate sodium | Capsule | 100 mg | |
| docusate sodium | Oral liquid | 50 mg/5 ml | |
| fluoxetine | Tablet | 20 mg | a |
| haloperidol | Injection | 5 mg/mL | |
| haloperidol | Oral liquid | 2 mg/mL | |
| haloperidol | Solid oral dosage form | 0.5 mg | |
| haloperidol | Tablet | 2 mg | |
| haloperidol | Tablet | 5 mg | |
| hyoscine butylbromide | Injection | 20 mg/ml in 1-mL ampoule | |
| hyoscine hydrobromide | Transdermal patches | 1 mg/72 hours | |
| lactulose | Oral liquid | 3.1-3.7 g/5 ml | |
| loperamide | Tablet | 2 mg | |
| metoclopramide | Injection | 5 mg/ml (hydrochloride) | |
| metoclopramide | Oral liquid | 5 mg/5 mL | |
| metoclopramide | Tablet | 10mg | |
| midazolam | Injection | 1 mg/ml | |
| midazolam | Injection | 5 mg/mL | |
| midazolam | Oral liquid | 2 mg/ml | |
| midazolam | Tablet | 15 mg | |
| midazolam | Tablet | 7.5 mg | |
| ondansetron | Injection | 2 mg/ml | |
| ondansetron | Oral liquid | 4 mg base/5 ml | |
| ondansetron | Tablet | 4 mg | |
| ondansetron | Tablet | 8 mg | |
| senna | Oral liquid | 7.5 mg/5 ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| dexamethasone | Injection | 4 mg/mL | |
| epinephrine (adrenaline) | Injection | 1 mg (hydrochloride)/mL | |
| hydrocortisone | Powder for injection | 100 mg (as sodium succinate) in vial | |
| loratadine | Oral liquid | 1mg/ml | |
| loratadine | Tablet | 10 mg | |
| prednisolone | Oral liquid | 5 mg/mL | |
| prednisolone | Tablet | 25 mg | |
| prednisolone | Tablet | 5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| charcoal, activated | Powder | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| atropine | Injection | 1 mg/ml | |
| atropine | Oral liquid | 10% | |
| atropine | Oral liquid | 20% | |
| calcium gluconate | Injection | 100 mg/mL in 10-mL ampoule | |
| methylthioninium chloride (methylene blue) | Injection | 10 mg/ml | |
| N-Acetylcysteine | Injection | 200 mg/mL | |
| naloxone | Injection | 0.4 mg/mL | |
| protamine sulfate | Injection | 10 mg/mL | |
| sodium nitrite | Injection | 30 mg/mL | |
| sodium thiosulfate | Injection | 250 mg/mL |
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| deferoxamine | Powder for injection | 500 mg | |
| dimercaprol | Injection | 50 mg/ml | |
| edetate calcium disodium | Solution for injection | 200 mg/ ml | |
| fomepizole | Injection | 1 g/mL | |
| fomepizole | Injection | 5 mg/mL | |
| succimer | Solid oral dosage form | 100 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| carbamazepine | Oral liquid | 100 mg/5 ml | |
| carbamazepine | Tablet | 100 mg | |
| carbamazepine | Tablet | 200 mg | |
| diazepam | Injection | 10 mg/mL | |
| diazepam | Tablet | 10 mg | |
| diazepam | Tablet | 2 mg | |
| diazepam | Tablet | 5 mg | |
| ethosuximide | Oral liquid | 250 mg/5 ml | |
| lamotrigine | Tablet | 100 mg | |
| lamotrigine | Tablet | 200 mg | |
| lamotrigine | Tablet | 25 mg | |
| lamotrigine | Tablet | 50 mg | |
| lamotrigine | Tablet (buffered chewable, dispersible) | 100 mg | |
| lamotrigine | Tablet (buffered chewable, dispersible) | 2 mg | |
| lamotrigine | Tablet (buffered chewable, dispersible) | 200 mg | |
| lamotrigine | Tablet (buffered chewable, dispersible) | 25 mg | |
| lamotrigine | Tablet (buffered chewable, dispersible) | 5 mg | |
| lamotrigine | Tablet (buffered chewable, dispersible) | 50 mg | |
| lorazepam | Injection | 2 mg/mL | |
| lorazepam | Injection | 4 mg/ml | |
| magnesium sulfate | Injection | 500 mg/mL in 10-mL ampoule | |
| magnesium sulfate | Injection | 500 mg/mL in 2-mL ampoule | |
| midazolam | Injection | 1 mg/ml | |
| midazolam | Injection | 10 mg/ml | |
| midazolam | Injection | 5 mg/mL | |
| phenobarbital | Oral liquid | 15 mg/5 mL | |
| phenobarbital | Tablet | 15 mg to 100 mg | |
| phenytoin | Injection | 50 mg/mL | |
| phenytoin | Tablet | 100 mg | |
| phenytoin | Tablet | 25 mg | |
| phenytoin | Tablet | 50 mg | |
| valproic acid (sodium valproate) | Oral liquid | 200 mg/5 ml | |
| valproic acid (sodium valproate) | Tablet | 100 mg | |
| valproic acid (sodium valproate) | Tablet | 200 mg | |
| valproic acid (sodium valproate) | Tablet | 500 mg |
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ethosuximide | Capsule | 250 mg | |
| valproic acid (sodium valproate) | Injection | 100mg/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| albendazole | Tablet | 400 mg | |
| mebendazole | Tablet | 100 mg | |
| mebendazole | Tablet | 500 mg | |
| praziquantel | Syrup | 50 mg/mL | |
| praziquantel | Tablet | 150 mg | |
| praziquantel | Tablet | 600 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| albendazole | Tablet | 400 mg | |
| diethylcarbamazine | Tablet | 100 mg (dihydrogen citrate) | |
| diethylcarbamazine | Tablet | 50 mg (dihydrogen citrate) | |
| ivermectin | Tablet | 3 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amoxicillin | Suspension | 125 mg/ 5 ml | |
| amoxicillin | Suspension | 250 mg/5ml | |
| amoxicillin | Tablet | 250 mg | |
| amoxicillin | Tablet | 500 mg | |
| amoxicillin + clavulanic acid | Oral liquid | 125 mg amoxicillin + 31.25 mg clavulanic acid/5 ml | |
| amoxicillin + clavulanic acid | Tablet | 500 mg (as trihydrate) + 125 mg (as potassium salt) | |
| ampicillin | Powder for injection | 1 g (as sodium salt) in vial | |
| ampicillin | Powder for injection | 500 mg (as sodium salt) in vial | |
| benzathine benzylpenicillin | Powder for injection | 1.44 g benzylpenicillin (= 2.4 million IU) in 5-ml vial | |
| benzathine benzylpenicillin | Powder for injection | 900 mg benzylpenicillin (= 1.2 million IU) in 5-ml vial | |
| benzylpenicillin | Powder for injection | 3 g (= 5 million IU) (sodium or potassium salt) in vial | |
| benzylpenicillin | Powder for injection | 600 mg (= 1 million IU) (sodium or potassium salt) in vial | |
| cefalexin | Oral liquid | 125 mg/5 mL | |
| cefalexin | Oral liquid | 250 mg/5 mL | |
| cefalexin | Tablet | 250 mg | |
| cefazolin | Powder for injection | 1 g (as sodium salt) in vial | |
| cefixime | Capsule | 400 mg (as trihydrate) | |
| cefotaxime | Powder for injection | 250 mg | |
| ceftazidime | Injection | 1 g | |
| ceftazidime | Injection | 500 mg | |
| ceftriaxone | Injection | 250 mg to 1000 g | |
| cloxacillin | Capsule | 1 g (as sodium salt) | |
| cloxacillin | Capsule | 500 mg | |
| cloxacillin | Powder for injection | 500 mg (sodium salt) | |
| flucloxacillin | Oral liquid | 125 mg/5 mL (sodium salt) | |
| phenoxymethylpenicillin | Powder for oral liquid | 250 mg (as potassium salt)/5 ml | |
| phenoxymethylpenicillin | Tablet | 250 mg (as potassium salt) | |
| piperacillin sodium + tazobactum sodium | Injection | 2 g (as sodium) + 250 mg (as sodium) in vial | |
| piperacillin sodium + tazobactum sodium | Solution for injection | 4 g/ 500 mg | |
| procaine benzylpenicillin | Powder for injection | 1 g (=1 million IU) in vial | |
| procaine benzylpenicillin | Powder for injection | 3 g (=3 million IU) in vial |
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| cefepime | Injection | 1 g in vial | |
| cefepime | Solution for injection | 500 mg | |
| ceftaroline | Injection | 400 mg- 600 mg | |
| meropenem | Injection | 1g | |
| meropenem | Injection | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| azithromycin | Oral liquid | 200 mg/5 mL | |
| azithromycin | Tablet | 250 mg | |
| azithromycin | Tablet | 500 mg | |
| ciprofloxacin | Oral liquid | 125 mg/5 mL | |
| ciprofloxacin | Oral liquid | 250 mg/5 ml (anhydrous) | |
| ciprofloxacin | Tablet | 250 mg | |
| ciprofloxacin | Tablet | 500 mg | |
| clarithromycin | Suspension | 125 mg/5 ml | |
| clarithromycin | Suspension | 250 mg/5 ml | |
| clarithromycin | Tablet | 500 mg | |
| clindamycin | Capsule | 150 mg | |
| clindamycin | Injection | 150 mg/mL | |
| clindamycin | Suspension | 75 mg/5mL | |
| doxycycline | Capsule | 100 mg | a |
| doxycycline | Oral liquid | 25 mg/5 ml (anhydrous) | a |
| doxycycline | Oral liquid | 50 mg/5 ml (anhydrous) | a |
| erythromycin | Oral liquid | 125 mg (estolate)/5 mL | |
| erythromycin | Tablet | 250 mg | |
| erythromycin | Tablet | 500 mg | |
| gentamicin | Injection | 10 to 40mg/ml | |
| metronidazole | Injection | 500 mg in 100-mL vial | |
| metronidazole | Suspension | 200 mg/ 5 ml | |
| metronidazole | Tablet | 200 mg to 500 mg | |
| nitrofurantoin | Oral liquid | 25 mg/5 ml | |
| nitrofurantoin | Tablet | 100 mg | |
| sulfamethoxazole + trimethoprim | Injection | 80 mg + 16 mg/mL in 10-mL ampoule | |
| sulfamethoxazole + trimethoprim | Injection | 80 mg + 16 mg/mL in 5-mL ampoule | |
| sulfamethoxazole + trimethoprim | Oral liquid | 200 mg + 40 mg/5 mL | |
| sulfamethoxazole + trimethoprim | Tablet | 100 mg + 20 mg | |
| sulfamethoxazole + trimethoprim | Tablet | 400 mg + 80 mg | |
| sulfamethoxazole + trimethoprim | Tablet | 800 mg + 160 mg | |
| tetracycline | Solid oral dosage form | 250 mg | |
| trimethoprim | Tablet | 100 mg | |
| trimethoprim | Tablet | 200 mg | |
| vancomycin | Injection | 250 mg | |
| vancomycin | Injection | 500 mg |
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ciprofloxacin | Injection | 2mg (lactate)/ml | |
| levofloxacin | Tablet | 500 mg | |
| linezolid | injection for intravenous administration | 2 mg/ ml | |
| linezolid | Powder for oral liquid | 100 mg/ 5 ml | |
| linezolid | Tablet | 400 mg | |
| linezolid | Tablet | 600 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| clofazimine | Capsule | 100 mg | |
| clofazimine | Capsule | 50 mg | |
| dapsone | Tablet | 100 mg | |
| dapsone | Tablet | 25 mg | |
| dapsone | Tablet | 50 mg | |
| rifampicin | Solid oral dosage form | 150 mg | |
| rifampicin | Solid oral dosage form | 300 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ethambutol | Oral liquid | 25 mg/ml | |
| ethambutol | Tablet | 100 mg | |
| ethambutol | Tablet | 400mg | |
| ethambutol + isoniazid + pyrazinamide + rifampicin | Tablet | 275 mg + 75 mg + 400 mg + 150 mg | |
| ethambutol + isoniazid + rifampicin | Tablet | 275 mg + 75 mg + 150 mg | |
| isoniazid | Oral liquid | 50 mg/5 ml | |
| isoniazid | Tablet | 300 mg | |
| isoniazid | Tablet (scored) | 50 mg | |
| isoniazid + pyrazinamide + rifampicin | Tablet | 30 mg/ 150 mg/ 60mg | |
| isoniazid + pyrazinamide + rifampicin | Tablet | 75 mg + 400 mg + 150 mg | |
| isoniazid + rifampicin | Tablet | 150 mg + 150 mg | |
| isoniazid + rifampicin | Tablet | 150 mg + 300 mg | |
| isoniazid + rifampicin | Tablet | 60 mg + 60 mg | |
| isoniazid + rifampicin | Tablet | 75 mg + 150 mg | |
| isoniazid + rifampicin | Tablet (dispersible) | 50 mg + 75 mg | |
| pyrazinamide | Tablet | 400 mg | |
| pyrazinamide | Tablet (dispersible) | 150 mg | |
| pyrazinamide | Tablet (dispersible) | 150 mg | |
| rifabutin | Capsule | 150 mg | |
| rifampicin | Oral liquid | 20 mg/ml | |
| rifampicin | Solid oral dosage form | 300 mg | |
| rifampicin | Tablet | 150 mg |
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amikacin | Powder for injection | 1 g (as sulfate) in vial | |
| amikacin | Powder for injection | 100 mg (as sulfate) in vial | |
| amikacin | Powder for injection | 500 mg (as sulfate) in vial | |
| capreomycin | Powder for injection | 1 g (as sulfate) in vial | |
| cycloserine | Solid oral dosage form | 125 mg | |
| cycloserine | Solid oral dosage form | 250 mg | |
| ethionamide | Tablet | 125 mg | |
| ethionamide | Tablet | 250 mg | |
| kanamycin | Powder for injection | 1g | |
| levofloxacin | Tablet | 250 mg | |
| levofloxacin | Tablet | 500 mg | |
| levofloxacin | Tablet | 750 mg | |
| moxifloxacin | Tablet | 400 mg | |
| p-aminosalicylic acid | Granules | 4 g in sachet | |
| streptomycin | Powder for injection | 1 g |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| clotrimazole | Cream | 1% | |
| clotrimazole | Cream | 10% | |
| clotrimazole | Vaginal tablet | 100 mg | |
| clotrimazole | Vaginal tablet | 500 mg | |
| fluconazole | Injection | 2 mg/mL in vial | |
| fluconazole | Oral liquid | 50 mg/5 mL | |
| fluconazole | Tablet | 150 mg | |
| fluconazole | Tablet | 50 mg | |
| griseofulvin | Suspension | 125 mg/ 5 ml | |
| griseofulvin | Tablet | 125 mg | |
| griseofulvin | Tablet | 250 mg | |
| griseofulvin | Tablet | 500mg | |
| nystatin | Oral liquid | 100 000 IU/ml | |
| nystatin | Oral liquid | 50 mg/5 ml | |
| nystatin | Pessary | 100 000 IU | |
| nystatin | Tablet | 100 000 IU | |
| nystatin | Tablet | 500 000 IU |
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amphotericin B | Injection | 50 mg | |
| flucytosine | Capsule | 250 mg | |
| flucytosine | Infusion | 2.5 g in 250 ml | |
| itraconazole | Capsule | 100 mg | |
| itraconazole | Oral solution | 10 mg/ ml | |
| voriconazol | Powder for injection | 200 mg in vial | |
| voriconazol | Powder for oral liquid | 40 mg/ ml | |
| voriconazol | Tablet | 200 mg | |
| voriconazol | Tablet | 50 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| abacavir | Tablet | 300 mg | |
| abacavir (ABC) | Oral liquid | 20mg/ml | |
| emtricitabine (FTC) | Capsule | 200 mg | |
| lamivudine (3TC) | Oral liquid | 50 mg/5 ml | |
| lamivudine (3TC) | Tablet | 150 mg | |
| tenofovir disoproxil fumarate | Tablet | 300 mg | |
| zidovudine (ZDV or AZT) | Capsule | 100 mg | |
| zidovudine (ZDV or AZT) | Oral liquid | 50 mg/5 mL | |
| zidovudine (ZDV or AZT) | Tablet | 300 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| efavirenz (EFV or EFZ) | Capsule | 600 mg | |
| efavirenz (EFV or EFZ) | Oral liquid | 150 mg/5 ml | |
| efavirenz (EFV or EFZ) | Tablet | 100 mg | |
| efavirenz (EFV or EFZ) | Tablet | 50 mg | |
| efavirenz (EFV or EFZ) | Tablet (scored) | 200 mg | |
| etravirine | Tablet | 100 mg | |
| etravirine | Tablet | 200 mg | |
| nevirapine (NVP) | Oral liquid | 50 mg/5 ml | |
| nevirapine (NVP) | Tablet | 200 mg | |
| nevirapine (NVP) | Tablet | 50 mg | |
| nevirapine (NVP) | Tablet (dispersible) | 50 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| atazanavir + ritonavir | Tablet | 300 mg + 100 mg | |
| darunavir | Tablet | 400 mg | |
| darunavir | Tablet | 600 mg | |
| darunavir | Tablet | 75 mg | |
| darunavir | Tablet | 800 mg | |
| lopinavir + ritonavir (LPV/r) | Oral liquid | 80 + 20 mg/ml | |
| lopinavir + ritonavir (LPV/r) | Solid oral dosage form | 40 mg + 10 mg | |
| lopinavir + ritonavir (LPV/r) | Tablet | 100 mg/ 25 mg | |
| lopinavir + ritonavir (LPV/r) | Tablet | 200 mg/ 50 mg | |
| ritonavir | Oral liquid | 400 mg/5 ml | |
| ritonavir | Tablet | 100 mg | |
| ritonavir | Tablet | 25 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| dolutegravir | Tablet | 50 mg | |
| raltegavir | Tablet | 400 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| abacavir + lamivudine | Tablet | 120 mg/ 60 mg | |
| abacavir + lamivudine | Tablet | 600 mg/ 300 mg | |
| abacavir + lamivudine | Tablet | 600mg + 300mg | |
| dolutegravir + lamivudina + tenofovir | Tablet | 50 mg + 300 mg + 300 mg (tenofovir disoproxil fumarate – equivalent to 245 mg tenofovir disoproxil) | |
| efavirenz + emtricitabine + tenofovir | Tablet | 600 mg + 200 mg + 300 mg | |
| emtricitabine + tenofovir | Tablet | 200 mg + 300 mg | |
| lamivudine + nevirapine + zidovudine | Tablet | 150 mg + 200 mg + 300 mg | |
| lamivudine + nevirapine + zidovudine | Tablet | 30 mg + 50 mg + 60 mg | |
| lamivudine + zidovudine | Tablet | 150 mg + 300 mg | |
| lamivudine + zidovudine | Tablet (dispersible, scored) | 30 mg + 60 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ganciclovir | Powder for injection | 500 mg | |
| ribavirin | injection for intravenous administration | 1 g in 10-ml phosphate buffer solution | |
| ribavirin | injection for intravenous administration | 800 mg in 10-ml phosphate buffer solution | |
| ribavirin | Solid oral dosage form | 200 mg | |
| ribavirin | Solid oral dosage form | 400 mg | |
| ribavirin | Solid oral dosage form | 600 mg | |
| valgancyclovir | Tablet | 450mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| entecavir | Oral liquid | 0.05 mg/ ml | |
| entecavir | Tablet | 0.5 mg | |
| entecavir | Tablet | 1 mg | |
| tenofovir disoproxil fumarate | Tablet | 300 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ribavirin | injection for intravenous administration | 1 g in 10-ml phosphate buffer solution | |
| ribavirin | injection for intravenous administration | 800 mg in 10-ml phosphate buffer solution | |
| ribavirin | Solid oral dosage form | 200 mg | |
| ribavirin | Solid oral dosage form | 400 mg | |
| ribavirin | Solid oral dosage form | 600 mg |
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| daclatasvir | Capsule | 30 mg | |
| daclatasvir | Capsule | 60 mg | |
| interferon alpha | Injection | Pegylated interferon alfa (2a or 2b) 100 mg | |
| interferon alpha | Injection | Pegylated interferon alfa (2a or 2b) 180 mg | |
| interferon alpha | Injection | Pegylated interferon alfa (2a or 2b) 80 mg | |
| ledipasvir + sofosbuvir | Tablet | 90 mg/ 400 mg | |
| sofosbuvir | Tablet | 400 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| metronidazole | Injection | 500 mg in 100-mL vial | |
| metronidazole | Suspension | 125 mg/5 mL | |
| metronidazole | Suspension | 250 mg/5 mL | |
| metronidazole | Tablet | 200 mg to 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| artemether + lumefantrine | Tablet | 20 mg + 120 mg | a |
| artesunate + mefloquine | Tablet | 100 mg + 220 mg | |
| artesunate + mefloquine | Tablet | 25mg; 55mg | |
| chloroquine | Oral liquid | 50 mg (as phosphate or sulfate)/5 ml | |
| chloroquine | Tablet | 150 mg | |
| clindamycin | Capsule | 150 mg | |
| doxycycline | Tablet | 100mg | |
| primaquine | Tablet | 15 mg | |
| primaquine | Tablet | 7.5 mg | |
| quinine | Injection | 300 mg quinine hydrochloride/mL in 2-mL ampoule |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chloroquine | Oral liquid | 50 mg (as phosphate or sulfate)/5 ml | |
| chloroquine | Tablet | 150 mg | |
| clindamycin | Capsule | 150 mg | |
| doxycycline | Tablet | 100mg | |
| mefloquine | Tablet | 250 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| pyrimethamine | Tablet | 25 mg | |
| sulfamethoxazole + trimethoprim | Solution for injection | 80 mg/ml / 16 mg/ ml | |
| sulfamethoxazole + trimethoprim | Tablet | 100 mg + 20 mg | |
| sulfamethoxazole + trimethoprim | Tablet | 400 mg + 80 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetylsalicylic acid | Tablet | 300 mg to 500 mg | |
| paracetamol | Oral liquid | 120 mg/5 mL | |
| paracetamol | Oral liquid | 125 mg/5 ml | |
| paracetamol | Tablet | 300 mg to 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| propranolol | Tablet | 20 mg | |
| propranolol | Tablet | 40mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| trastuzumab | Injection | 60 mg |
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| all trans retinoid acid (ATRA) | Capsule | 10 mg | |
| allopurinol | Tablet | 100 mg | |
| allopurinol | Tablet | 300 mg | |
| asparaginase | Injection | 10000 UI | |
| bendamustine | Injection | 180 mg/2 mL | |
| bendamustine | Injection | 45 mg/0.5 mL | |
| bleomycin | Powder for injection | 15 mg (as sulfate) in vial | |
| calcium folinate | Injection | 3 mg/mL in 10-mL ampoule | |
| calcium folinate | Tablet | 15 mg | |
| capecitabine | Tablet | 150 mg | |
| capecitabine | Tablet | 500 mg | |
| carboplatin | Injection | 150 mg/15 mL | |
| carboplatin | Injection | 450 mg/45 mL | |
| carboplatin | Injection | 50 mg/5 mL | |
| carboplatin | Injection | 600 mg/60 mL | |
| chlorambucil | Tablet | 2 mg | |
| cisplatin | Injection | 100 mg/100 mL | |
| cisplatin | Injection | 50 mg/ 50 ml | |
| cyclophosphamide | Tablet | 25 mg | |
| cytarabine | Powder for injection | 100 mg in vial | |
| cytarabine | Powder for injection | 50 mg | |
| dacarbazine | Powder for injection | 100 mg in vial | |
| dactinomycin | Powder for injection | 500 mcg in vial | |
| daunorubicin | Injection | 50 mg | |
| docetaxel | Injection | 20 mg/ml | |
| docetaxel | Injection | 40 mg/mL | |
| doxorubicin | Powder for injection | 10 mg (hydrochloride) in vial | |
| doxorubicin | Powder for injection | 50 mg (hydrochloride) in vial | |
| etoposide | Capsule | 100 mg | |
| etoposide | Injection | 20 mg/mL in 5-mL ampoule | |
| filgrastim | Injection | 120 micrograms/0.2 mL in pre-filled syringe. | |
| filgrastim | Injection | 300 micrograms/0.5 mL in pre-filled syringe. | |
| filgrastim | Injection | 300 micrograms/mL in 1 mL vial | |
| filgrastim | Injection | 480 micrograms/0.8 mL in pre-filled syringe | |
| filgrastim | Injection | 480 micrograms/1.6 mL in 1.6 mL vial | |
| fludarabine | Injection | 50 mg (phosphate) | |
| fludarabine | Tablet | 10 mg | |
| fluorouracil | Injection | 50 mg/5 mL | |
| gemcitabine | Injection | 1g | |
| gemcitabine | Injection | 200mg | |
| hydroxycarbamide | Solid oral dosage form | 1 g | |
| hydroxycarbamide | Solid oral dosage form | 200 mg | |
| hydroxycarbamide | Solid oral dosage form | 250 mg | |
| hydroxycarbamide | Solid oral dosage form | 300 mg | |
| hydroxycarbamide | Solid oral dosage form | 400 mg | |
| hydroxycarbamide | Solid oral dosage form | 500 mg | |
| ifosfamide | Powder for injection | 1 g in vial | |
| ifosfamide | Powder for injection | 2 g in vial | |
| ifosfamide | Powder for injection | 500 mg vial | |
| imatinib | Tablet | 100 mg (as mesylate) | |
| imatinib | Tablet | 400 mg (as mesylate) | |
| irinotecan | Injection | 100 mg/ 5 ml in 5 ml vial | |
| irinotecan | Injection | 40 mg/ 2 ml in 2 ml vial | |
| irinotecan | Injection | 500 mg/ 25 ml in 25 ml vial | |
| melphalan | Injection | 50 mg/mL | |
| melphalan | Tablet | 2 mg | |
| mercaptopurine | Tablet | 50 mg | |
| mesna | Injection | 100 mg/ml in 10-ml ampoules | |
| mesna | Injection | 100 mg/ml in 4-ml ampoules | |
| mesna | Tablet | 400 mg | |
| mesna | Tablet | 600 mg | |
| methotrexate | Injection | 2.5 mg/mL | |
| methotrexate | Tablet | 2.5 mg | |
| oxaliplatin | Injection | 100 mg | |
| oxaliplatin | Injection | 100 mg/ 20 ml in 20 ml vial | |
| oxaliplatin | Injection | 200 mg/ 40 ml in 40 ml vial | |
| oxaliplatin | Injection | 50 mg | |
| oxaliplatin | Injection | 50 mg/ 10 ml in 10 ml vial | |
| paclitaxel | Powder for injection | 6 mg/ml | |
| procarbazine | Capsule | 50 mg | |
| rituximab | Injection | 10 mg/mL in 10-mL vial | |
| rituximab | Injection | 500 mg/50 mL | |
| thalidomide | Tablet | 100 mg | |
| thalidomide | Tablet | 50 mg | |
| trastuzumab | Injection | 150 mg | |
| trastuzumab | Injection | 440 mg | |
| vinblastine | Injection | 10 mg | |
| vincristine | Injection | 1 mg/mL | |
| vincristine | Injection | 5 mg/mL | |
| vinorelbine | Injection | 10 mg/mL | |
| vinorelbine | Injection | 50 mg | |
| zoledronic acid | Concentrate for solution for infusion | 4 mg/ 5 ml in 5 ml vial | |
| zoledronic acid | Solution for IV infusion | 4 mg/ 100 ml in 100 ml bottle |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| anastrozole | Tablet | 1mg | |
| bicalutamide | Tablet | 50 mg | |
| dexamethasone | Injection | 30 mg/mL | |
| dexamethasone | Oral liquid | 2 mg/5 mL | |
| hydrocortisone | Powder for injection | 100 mg (as sodium succinate) in vial | |
| leuprorelin | Injection | 1 mg/0.2 ml in vial 2.8ml | |
| methylprednisolone | Injection | 40 mg/ml | |
| methylprednisolone | Injection | 80 mg (acetate)/mL | |
| prednisolone | Tablet | 25 mg | |
| prednisolone | Tablet | 5 mg | |
| tamoxifen | Tablet | 10 mg (as citrate) | |
| tamoxifen | Tablet | 20 mg (as citrate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| biperiden | Injection | (lactate) 5 mg/mL | |
| biperiden | Tablet | (lactate) 2 mg | |
| levodopa + carbidopa | Capsule | 250mg + 25mg | |
| levodopa + carbidopa | Tablet | 100 mg + 10 mg | |
| levodopa + carbidopa | Tablet | 250 mg + 25 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ferrous fumarate + folic acid | Tablet | 60 mg + 400 mcg | |
| ferrous sulfate | Oral solution | 25 mg/ ml | |
| folic acid | Syrup | 1 mg | |
| folic acid | Syrup | 5 mg | |
| folic acid | Tablet | 0.4 mg | |
| folic acid | Tablet | 1 mg | |
| folic acid | Tablet | 5 mg | |
| hydroxocobalamin | Injection | 1 mg/mL |
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| erythropoiesis - stimulating agents | injection: pre- filled syringe | 1000 IU/ 0.5 mL | |
| erythropoiesis - stimulating agents | injection: pre- filled syringe | 10000 IU/1 mL | |
| erythropoiesis - stimulating agents | injection: pre- filled syringe | 20 000 IU/ 0.5 mL | |
| erythropoiesis - stimulating agents | injection: pre- filled syringe | 2000 IU/ 0.5 mL | |
| erythropoiesis - stimulating agents | injection: pre- filled syringe | 3000 IU/ 0.3 mL | |
| erythropoiesis - stimulating agents | injection: pre- filled syringe | 40 000 IU/ 1 mL | |
| erythropoiesis - stimulating agents | injection: pre- filled syringe | 4000 IU/ 0.4 mL | |
| erythropoiesis - stimulating agents | injection: pre- filled syringe | 5000 IU/ 0.5 mL | |
| erythropoiesis - stimulating agents | injection: pre- filled syringe | 6000 IU/ 0.6 mL | |
| erythropoiesis - stimulating agents | injection: pre- filled syringe | 8000 IU/ 0.8 mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| enoxaparin | Injection | 100 mg/ 1 mL | |
| enoxaparin | Injection | 120 mg/ 0.8 mL | |
| enoxaparin | Injection | 150 mg/ 1 mL | |
| enoxaparin | Injection | 20 mg/ 0.2ml | |
| enoxaparin | Injection | 40 mg/ 0.4 ml | |
| enoxaparin | Injection | 60 mg/ 0.6 ml | |
| enoxaparin | Injection | 80 mg/0.8 ml | |
| heparin sodium | Injection | 1000 U/ml | |
| heparin sodium | Injection | 20000 U/ml | |
| heparin sodium | Injection | 5000 U/ml | |
| phytomenadione | Injection | 1 mg/ ml | |
| phytomenadione | Injection | 10 mg/mL in 1-mL vial | |
| phytomenadione | Tablet | 10 mg | |
| protamine sulfate | Injection | 10 mg/mL | |
| tranexamic acid | Injection | 100 mg/ml | |
| warfarin | Tablet | 1 mg (sodium salt) | |
| warfarin | Tablet | 2 mg (sodium salt) | |
| warfarin | Tablet | 5 mg (sodium salt) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| deferoxamine | Powder for injection | 500 mg | |
| hydroxycarbamide | Solid oral dosage form | 1 g | |
| hydroxycarbamide | Solid oral dosage form | 200 mg | |
| hydroxycarbamide | Solid oral dosage form | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| dextran 70 | Parenteral solution | 6% | |
| fresh - frozen plasma | N/A | N/A | |
| platelets | N/A | N/A | |
| red blood cells | N/A | N/A | |
| whole blood | N/A | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| anti-D immunoglobulin (human) | Injection | 250 mcg in single-dose vial | |
| rabies immunoglobulin | Injection | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| factor VIII | Solution for injection | 500 UI |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| atenolol | Tablet | 100 mg | |
| atenolol | Tablet | 50 mg | |
| bisoprolol | Tablet | 1.25 mg | |
| bisoprolol | Tablet | 5 mg | |
| glyceryl trinitrate | Tablet (sublingual) | 500 mcg | |
| isosorbide dinitrate | Tablet (sublingual) | 5 mg |
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| carvedilol | Tablet | 12.5 mg | |
| carvedilol | Tablet | 25 mg | |
| carvedilol | Tablet | 3.125 mg | |
| carvedilol | Tablet | 6.25 mg | |
| metoprolol | Tablet | 100 mg | |
| metoprolol | Tablet | 25 mg | |
| metoprolol | Tablet | 50 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| atenolol | Tablet | 100 mg | |
| atenolol | Tablet | 50 mg | |
| digoxin | Injection | 0.5 mg in 2 mL ampoule | |
| digoxin | Injection | 250 micrograms/mL in 2-mL ampoule | |
| digoxin | Oral liquid | 50 micrograms/mL | |
| digoxin | Tablet | 250 mcg | |
| digoxin | Tablet | 62.5 micrograms | |
| epinephrine (adrenaline) | Injection | 100 mcg/mL | |
| lidocaine | Injection | 20 mg (hydrochloride)/ml in 5-ml ampoule | |
| verapamil | Injection | 2.5 mg/mL | |
| verapamil | Tablet | 40 mg | |
| verapamil | Tablet | 80 mg |
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amiodarone | Injection | 50 mg/ml | |
| amiodarone | Tablet | 100 mg | |
| amiodarone | Tablet | 200 mg | |
| amiodarone | Tablet (HCI) | 400 mg (hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amlodipine | Tablet | 5 mg | |
| atenolol | Tablet | 100 mg | |
| atenolol | Tablet | 50 mg | |
| bisoprolol | Tablet | 100 mg | |
| bisoprolol | Tablet | 50 mg | |
| chlorthalidone | Tablet | 12.5 mg | |
| chlorthalidone | Tablet | 25 mg | |
| enalapril | Tablet | 2.5 mg | |
| enalapril | Tablet | 5 mg | |
| enalapril | Tablet | 5 mg | |
| hydralazine | Injection | 25 mg/mL | |
| hydralazine | Tablet | 25 mg | |
| hydralazine | Tablet | 50 mg | |
| hydrochlorothiazide | Tablet | 12.5 mg | |
| hydrochlorothiazide | Tablet | 25 mg | |
| losartan | Tablet | 100 mg | |
| losartan | Tablet | 25 mg | |
| losartan | Tablet | 50mg | |
| methyldopa | Tablet | 250 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| atenolol | Tablet | 100 mg | |
| atenolol | Tablet | 50 mg | |
| bisoprolol | Tablet | 100 mg | |
| bisoprolol | Tablet | 50 mg | |
| digoxin | Tablet | 250 mcg | |
| enalapril | Tablet | 2.5 mg | |
| enalapril | Tablet | 5 mg | |
| furosemide | Injection | 10 mg/ml | |
| furosemide | Tablet | 40 mg | |
| hydrochlorothiazide | Tablet | 25 mg | |
| losartan | Tablet | 100 mg | |
| losartan | Tablet | 25 mg | |
| losartan | Tablet | 50mg | |
| spironolactone | Tablet | 25 mg |
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| dopamine | Injection | 40 mg/mL (hydrochloride) in 5-mL vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetylsalicylic acid | Tablet | 100 mg | |
| clopidogrel | Tablet | 300 mg | |
| clopidogrel | Tablet | 75 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| streptokinase | Powder for injection | 1.5 million IU in vial |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| simvastatin | Tablet | 10 mg | |
| simvastatin | Tablet | 20 mg | |
| simvastatin | Tablet | 40 mg | |
| simvastatin | Tablet | 5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| miconazole | Cream | 2% (nitrate) | |
| selenium sulfide | Suspension | 2% | |
| terbinafine | Cream | 1% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| mupirocin | Ointment | 2% | |
| potassium permanganate | Aqueous solution | 1:10 000 | |
| silver sulfadiazine | Cream | 1% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| betamethasone | Topical forms | 1% | |
| calamine | Lotion | 8% | |
| hydrocortisone | Cream | 1% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| benzoyl peroxide | Cream | 5% | |
| fluorouracil | Ointment | 5% | |
| podophyllin | Solution | 10% to 25% | |
| salicylic acid | Solution | 5% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| benzyl benzoate | Lotion | 25% | |
| permethrin | Cream | 5% | |
| permethrin | Lotion | 1% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| fluorescein | Solution (eye drops) | 1% | |
| tropicamide | Solution (eye drops) | 0.5% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amidotrizoate | Injection | 140 mg/mL | |
| amidotrizoate | Injection | 420 mg/mL | |
| barium sulfate | Suspension | 150 mg in 500mLs | |
| iohexol | Injection | 140 mg- 350 mg iodine/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| alcohol based hand rub | Solution | containing ethanol 80% volume/volume | |
| chlorhexidine | Solution | 5% | |
| chlorhexidine | Solution | 7% | |
| ethanol | Solution | 70% (denatured) | |
| iodine-povidone | Solution | 10% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chlorine base compound | Powder | (0.1% available chlorine) for solution | |
| glutaraldehyde | Solution | 2% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| furosemide | Injection | 10 mg/ml | |
| furosemide | Tablet | 40 mg | |
| hydrochlorothiazide | Tablet | 25 mg | |
| mannitol | Injectable solution | 10% | |
| mannitol | Injectable solution | 20% | |
| spironolactone | Oral liquid | 10 mg/5 ml | |
| spironolactone | Oral liquid | 25 mg/5 ml | |
| spironolactone | Oral liquid | 5 mg/5 ml | |
| spironolactone | Tablet | 25 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| esomeprazole | Capsule | 40 mg | |
| omeprazole | Capsule | 20 mg | |
| omeprazole | Injection | 40 mg | |
| ranitidine | Injection | 25 mg/ml (hydrochloride) | |
| ranitidine | Syrup | 75 mg/ 5 ml | |
| ranitidine | Tablet | 150 mg | |
| ranitidine | Tablet | 300 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| dexamethasone | Injection | 4 mg/mL | |
| dexamethasone | Oral liquid | 0.5 mg/5 mL | |
| dexamethasone | Oral liquid | 2 mg/5 mL | |
| dexamethasone | Solid oral dosage form | 0.5 mg | |
| dexamethasone | Solid oral dosage form | 0.75 mg | |
| dexamethasone | Solid oral dosage form | 1.5 mg | |
| dexamethasone | Solid oral dosage form | 4 mg | |
| metoclopramide | Injection | 5 mg/ml (hydrochloride) | |
| metoclopramide | Oral liquid | 5 mg/5 mL | |
| metoclopramide | Tablet | 10mg | |
| ondansetron | Injection | 2 mg/ml | |
| ondansetron | Oral liquid | 4 mg base/5 ml | |
| ondansetron | Solid oral dosage form | Eq 24 mg base | |
| ondansetron | Solid oral dosage form | Eq 4 mg base | |
| ondansetron | Solid oral dosage form | Eq 8 mg base |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| sulfasalazine | Suppository | 500 mg | |
| sulfasalazine | Tablet | 500 mg |
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| hydrocortisone | Suppository | 25 mg (acetate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| senna | Tablet | 7.5 mg (sennosides) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| oral rehydration salts | Powder for dilution | 1 L | |
| oral rehydration salts | Powder for dilution | 200 ml | |
| oral rehydration salts | Powder for dilution | 500 ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| zinc | Tablet | 20mg | |
| zinc sulfate | Oral liquid | 10mg | |
| zinc sulfate | Oral liquid | 20 mg | |
| zinc sulfate | Tablet | 10 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| hydrocortisone | Tablet | 10 mg | |
| hydrocortisone | Tablet | 20 mg | |
| hydrocortisone | Tablet | 5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| testosterone | Injection | 200 mg (enanthate) in 1-mL ampoule |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ethinylestradiol + levonorgestrel | Tablet | 30 mcg + 150 mcg | |
| levonorgestrel | Tablet | 30 micrograms | |
| levonorgestrel | Tablet | 750 micrograms (pack of two) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| estradiol cypionate + medroxyprogesterone acetate | Injection | 5 mg + 25 mg | |
| medroxyprogesterone | Injection | 150 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| copper-containing device | N/A | T 380 mm2 |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| condoms | N/A | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| levonorgestrel-releasing implant | N/A | Two-rod levonorgestrel-releasing implant, each rod containing 75 mg of levonorgestrel (150 mg total) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| glibenclamide | Tablet | 2.5 mg | |
| glibenclamide | Tablet | 5 mg | |
| gliclazide | Solid oral dosage form | 30 mg | |
| gliclazide | Solid oral dosage form | 60 mg | |
| gliclazide | Solid oral dosage form | 80 mg | |
| glucagon | Injection | 1 mg/mL | |
| Insulin | Injection | (short acting) 100U/mL in 10 mL | |
| intermediate-acting insulin | Injection | 40 IU/ml in 10-ml vial | |
| metformin | Tablet | 500 mg | |
| NPH insulin (intermediate-acting insulin) | Injection | 100 IU/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| clomifene | Tablet | 50 mg (citrate) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| levothyroxine | Tablet | 100 mcg (sodium salt) | |
| levothyroxine | Tablet | 25 mcg (sodium salt) | |
| levothyroxine | Tablet | 50 mcg (sodium salt) |
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| Lugol's solution | Oral liquid | about 130 mg total iodine/ml | |
| potassium iodide | Tablet | 60 mg | |
| propylthiouracil | Tablet | 50 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| tuberculin, purified protein derivative (PPD) | Injection | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| anti rabies human serum | Solution for injection | 150 UI/ ml | |
| diphtheria antitoxin | Injection | 10 000 IU in vial | |
| diphtheria antitoxin | Injection | 20 000 IU in vial | |
| tetanus antitoxin | Injection | 1500 IU/ 1.5 ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| BCG vaccine | Injection | N/A | |
| cholera vaccine | N/A | N/A | |
| diphtheria, tetanus toxoid + pertussis vaccine | Injection | N/A | |
| hepatitis A vaccine | N/A | N/A | |
| hepatitis B vaccine | Injection | N/A | |
| human papilloma virus (HPV) vaccine | N/A | N/A | |
| meningococcal meningitis vaccine | N/A | N/A | |
| MR vaccine | Injection | measles, rubella | |
| mumps vaccine | N/A | N/A | |
| pentavalent vaccine | Injection | diphtheria-tetanu toxoid, whole cell pertussis, hepatitis B, H. influenzae b (Hib) | |
| poliomyelitis vaccine | Injection | N/A | |
| rabies vaccine | N/A | N/A | |
| tetanus vaccine | Injection | N/A | |
| typhoid vaccine | N/A | N/A | |
| varicella vaccine | N/A | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| atracurium | Injection | 10 mg/mL (besylate) | |
| neostigmine | Injection | 2.5 mg (metilsulfate) in 1-ml ampoule | |
| neostigmine | Injection | 500 mcg (methylsulfate) in 1-mL ampoule | |
| neostigmine | Tablet | 15 mg (bromide) | |
| succinylcholine chloride | Injection | 50 mg/ ml x 2 ml | |
| vecuronium | Powder for injection | 10 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| aciclovir | Eye ointment | 3% | |
| ciprofloxacin | Solution (eye drops) | 0.3% | |
| erythromycin | Eye ointment | 0.5% | |
| gentamicin | Solution (eye drops) | 0.3% | |
| tetracycline | Eye ointment | 1% (hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| prednisolone | Solution (eye drops) | 0.5% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| tetracaine | Solution (eye drops) | 0.5% (hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetazolamide | Tablet | 250 mg | |
| latanoprost | Solution (eye drops) | 0.005% | |
| pilocarpine | Solution (eye drops) | 2% (hydrochloride) | |
| pilocarpine | Solution (eye drops) | 4% (hydrochloride or nitrate) | |
| timolol | Solution (eye drops) | 0.25% (maleate) | |
| timolol | Solution (eye drops) | 0.5 % |
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| epinephrine (adrenaline) | Solution (eye drops) | 2% (as hydrochloride) |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| bevacizumab | Infusion | 25mg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ergometrine | Injection | 0,2 mg/ml | |
| oxytocin | Injection | 10 units/ml |
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| misoprostol | Tablet | 200 mcg | |
| misoprostol | Vaginal tablet | 25 mcg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| nifedipine | Immediate-release capsule | 10 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| intraperitoneal dialysis solution (of appropriate composition) | Parenteral solution | N/A | |
| sodium chloride | N/A | 0.9% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| fluphenazine | Injection | 25 mg (decanoate or enantate) in 1-mL ampoule | |
| risperidone | Solid oral dosage form | 0.5 mg to 6 mg |
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chlorpromazine | Injection | 25 mg/ ml | |
| chlorpromazine | Oral liquid | 25 mg (hydrochloride)/5 mL | |
| chlorpromazine | Tablet | 100 mg | |
| clozapine | Solid oral dosage form | 25 to 200 mg | |
| haloperidol | Injection | 5 mg/mL | |
| haloperidol | Oral liquid | 2 mg/mL | |
| haloperidol | Tablet | 0.5 mg | |
| haloperidol | Tablet | 2 mg | |
| haloperidol | Tablet | 5 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| amitriptyline | Tablet | 25 mg | |
| amitriptyline | Tablet | 75 mg | |
| fluoxetine | Solid oral dosage form | 20mg | a |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| carbamazepine | Tablet | 100 mg | |
| carbamazepine | Tablet | 200 mg | |
| divalproex sodium | Tablet | 500 mg | |
| lithium carbonate | Tablet | 300 mg | |
| valproic acid (sodium valproate) | Tablet | 200 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| clomipramine | Solid oral dosage form | 10 mg | |
| clomipramine | Solid oral dosage form | 25 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| nicotine replacement therapy (NRT) | Chewing gum | 2 mg (as polacrilex) | |
| nicotine replacement therapy (NRT) | Chewing gum | 4 mg (as polacrilex) | |
| nicotine replacement therapy (NRT) | Transdermal patches | 5 mg to 30 mg/16 hrs | |
| nicotine replacement therapy (NRT) | Transdermal patches | 7 mg to 21 mg/24 hrs |
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| beclometasone | Inhalation (aerosol) | 100 micrograms (dipropionate) per dose (as CFC free forms) | |
| beclometasone | Inhalation (aerosol) | 50 mcg (dipropionate) per dose (as CFC free forms) | |
| budesonide | Inhalation (aerosol) | 100 micrograms per dose | |
| budesonide | Inhalation (aerosol) | 200 micrograms per dose | |
| budesonide + formoterol | turbohaler | 6/100 mcg | |
| budesonide + formoterol | turbohaler | 6/200 mcg | |
| epinephrine (adrenaline) | Injection | 1 mg (hydrochloride)/mL | |
| ipratropium bromide | Solution for inhalation | 20 mcg/ dose | |
| salbutamol | Injection | 50 mcg (as sulfate)/mL in 5-mL ampoule | |
| salbutamol | Solution for inhalation | 5 mg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| oral rehydration salts | Powder for dilution | 1 L | |
| oral rehydration salts | Powder for dilution | 200 ml | |
| oral rehydration salts | Powder for dilution | 500 ml | |
| potassium chloride | Powder for solution | N/A |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| glucose | Injectable solution | 5% (isotonic) | |
| glucose | Injectable solution | 50% (hypertonic) | |
| glucose | Parenteral formulation | 10% | |
| glucose with sodium chloride | Injectable solution | 5% glucose, 0.45% sodium chloride (equivalent to 75 mmol/L Na+ and 75 mmol/L Cl-) | |
| glucose with sodium chloride | Injectable solution | 5% glucose, 0.9% sodium chloride (equivalent to 150 mmol/L Na+ and 150 mmol/L Cl-) | |
| potassium chloride | Injection | 11.2%, 20 mL | |
| potassium chloride | Solution for dilution | 7.5% (equivalent to K 1 mmol/ml and Cl 1 mmol/ml) | |
| ringer lactate solution | Parenteral formulation | N/A | |
| sodium bicarbonate | Injection | 8.4% | |
| sodium bicarbonate | Solution for IV infusion injection | 1.4% | |
| sodium chloride | N/A | 0.9% | |
| sodium chloride | Parenteral formulation | 0.45% |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| water for injection | N/A | 10-ml ampoules | |
| water for injection | N/A | 2-ml ampoules | |
| water for injection | N/A | 5-mL ampoules |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ascorbic acid | Tablet | 500 mg | |
| calcium gluconate | Injection | 100 mg/mL in 10-mL ampoule | |
| hydroxocobalamin | Injection | 1 mg/mL | |
| pyridoxine | Tablet | 25 mg (hydrochloride) | |
| riboflavin | Tablet | 5 mg | |
| thiamine | Tablet | 50 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetic acid | Topical | 2%, in alcohol | |
| budesonide | Nasal spray | 100 micrograms per dose | |
| ciprofloxacin | ear drops | 0.3% | |
| oxymethazoline | Nasal spray | 0.5 mg/ml | a |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| caffeine citrate | Injection | 20 mg/ml (equivalent to 10 mg caffeine base/ml) | |
| caffeine citrate | Oral liquid | 20 mg/ml (equivalent to 10 mg caffeine base/ml) | |
| chlorhexidine | Solution | 7.1% (digluconate) | |
| gentian violet | Solution | N/A |
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| ibuprofen | Solution for injection | 5 mg/mL | |
| prostaglandin E | Solution for injection | Prostaglandin E1: 0.5 mg/ml in alcohol | |
| prostaglandin E | Solution for injection | Prostaglandin E2: 1 mg/ml | |
| surfactant | Suspension for intratracheal instillation | 25 mg/ml | |
| surfactant | Suspension for intratracheal instillation | 80 mg/ml |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| dexamethasone | Injection | 4 mg/mL |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| allopurinol | Tablet | 100 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| chloroquine | Tablet | 100 mg (as phosphate or sulfate) | |
| chloroquine | Tablet | 150 mg (as phosphate or sulfate) |
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| azathioprine | Tablet | 50 mg | |
| hydroxychloroquine | Tablet | 200 mg | |
| methotrexate | Tablet | 2.5 mg | |
| penicillamine | Solid oral dosage form | 250 mg | |
| sulfasalazine | Tablet | 500 mg |
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|
Complementary list
| Medicine | Pharmaceutical form type | Composition | Observation |
|---|---|---|---|
| acetylsalicylic acid | Suppository | 50 mg to 150 mg | |
| acetylsalicylic acid | Tablet | 100 mg | |
| acetylsalicylic acid | Tablet | 500 mg |